SOCS-2 (Suppressor of Cytokine Signaling 2) is an integral component of the cellular framework designed to regulate cytokine signaling, which plays a pivotal role in maintaining the balance of immune responses, cell growth, and differentiation. As part of the SOCS family, SOCS-2 is specifically implicated in the negative feedback loop that controls the JAK/STAT signaling pathway, a critical mechanism for transducing extracellular cytokine signals into cellular responses. The primary function of SOCS-2 is to inhibit cytokine signaling, thereby preventing excessive activation that could lead to inflammation or autoimmune diseases. It accomplishes this by directly binding to JAK proteins, inhibiting their kinase activity, or by targeting specific signaling components for proteasomal degradation. Furthermore, SOCS-2 is involved in regulating growth hormone signaling, highlighting its role in controlling not only immune responses but also growth and metabolic processes within the body. The expression of SOCS-2 itself is induced by cytokines, indicating that its activation serves as a vital regulatory checkpoint within cytokine signaling cascades, ensuring that signaling is terminated at the appropriate time to prevent pathological conditions.
The activation of SOCS-2 is intricately linked to its role in modulating the JAK/STAT pathway. Upon cytokine binding to its receptor, the associated JAK kinases are activated, leading to the phosphorylation of STAT proteins, which then dimerize and translocate to the nucleus to affect gene expression. SOCS-2 is rapidly upregulated in response to this signaling, where it then exerts its inhibitory effects through several mechanisms. One primary mode of action involves the SOCS box domain of SOCS-2, which facilitates the ubiquitination and subsequent proteasomal degradation of signaling proteins, effectively attenuating the signal transduction initiated by cytokines. The activation and function of SOCS-2 highlight the complexity of cytokine signaling regulation, underscoring the importance of tightly controlled feedback mechanisms in preventing overactivation of immune responses and maintaining normal cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
May alter cytokine levels and potentially influence the expression or activity of SOCS2 through modulation of cytokine signaling pathways. | ||||||
Nifuroxazide | 965-52-6 | sc-204128 sc-204128A | 500 mg 5 g | $203.00 $520.00 | 5 | |
Can modulate the activity of STAT proteins and might influence the expression or activation of SOCS2. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By inhibiting mTOR signaling, it could impact various cellular processes, influencing SOCS2 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
May influence the activity or expression of SOCS2 by impacting downstream signaling pathways through PI3K inhibition. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Can alter the acetylation status of histones and other proteins, affecting the expression of SOCS2. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Might influence the expression of SOCS2 by modulating DNA methylation patterns. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Could affect protein turnover and alter the levels and availability of SOCS2. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
May impact protein folding and stability, influencing SOCS2 levels and activity. | ||||||
Wedelolactone | 524-12-9 | sc-200648 sc-200648A | 1 mg 5 mg | $110.00 $337.00 | 8 | |
By inhibiting IKK, it might impact NF-κB signaling and potentially the expression of SOCS2. | ||||||